1Luo HC,Cheng HH,Fu ZC,et al.IMRT combined with ADT for intermediate and advanced prostate cancer:long-term outcome of Chinese patients[J].APJCP,2012,14(8):4711-4715.
2Luo HC,Cheng LP,Fu ZC,et al.Long-term QOL outcomes in patients with locally advanced prostate cancer after IMRT combined with ADT[J].Med Oncol,2014,31(6):991.
3Yang J,Zhong F,Qiu J,et al.Cognitive function in Chinese prostate cancer patients on androgen-deprivation therapy:A cross-sectional study[J].Asia Pac J Clin Oncol,2015,9[Epub ahead of print].
4Moehler M,Gockel I,Roessler HP,et al.Prospective,open,multi-centre phase Vll trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction[J].BMC Cancer,2013,11(13):75.
5Bekkum JE,Hilton S.The challenges of communicating research evidence in practice:perspectives from UK health visitors and practice nurses[J].BMC Nurs,2013,12(1):17.
6Sabbadin C,Done G,Bordin L,et al.Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient:case report and literature review[J].BMC Endocr Disord,2015,15(1):4.
7Kainth DS,Adil MM,Kainth HS,et al.Unsustainable hospital charges are incurred in the treatment of Medicare beneficiaries admitted with subarachnoid hemorrhage[J].J Vasc Interv Neurol,2014,7(5):56-63.
8Chen N,Wang JR,Huang L,et al Significant Association of Alpha-Methylacyl-CoA Racemase Gene Polymorphisms with Susceptibility to Prostate Cancer:a Meta-Analysis[J].Asian Pac J Cancer Prev,2015,16(5):1857-1863.
9Niu L,Zhou L,Xu K,et al.The role of cryosurgery in palliative care for cancer[J].Ann Palliat Med,2013,2(1):26-34.
10Cai J,Preblick R,Zhang Q,et al.Utilization of parenteral anticoagulants and warfarin:impact on the risk of venous thromboembolism recurrence in the outpatient setting[J].Am Health Drug Benefits,2014,7(8):444-451.
